Friday, September 3, 2021

Fetal Monitoring Market Size | Incredible Possibilities and Growth Analysis and Forecast To 2030


Fetal monitoring devices are vital tools that are routinely used in gynecology and obstetrics interventions to examine fetal health during labor & delivery. These devices are also used to monitor three key fetal/maternal parameters such as fetal heart rate, fetal movements, and uterine contractions.

The fetal monitoring market was valued at $2.93 billion in 2019 and is expected to reach $4.25 billion by 2027, registering a CAGR of 5.3% from 2020 to 2027.

Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/1890

The major factors that drive the global fetal monitoring market include increase in birth rates & preterm births, active government and nongovernment initiatives to provide better maternal & fetal care, and rise in technological advancements pertaining to these devices. For instance, STAN monitor from Neoventa Medical and Monica AN24 monitor, few novel technologies for fetal heart monitoring, are gaining significant foothold in the fetal monitoring market. However, stringent regulatory procedures and high costs associated with these devices are anticipated to restrain the market growth.

The ultrasound segment is anticipated to maintain its dominance during the forecast period, accounting for over one-third share of the global fetal monitoring market revenue by 2027. This is due to recent developments in ultrasound technologies, especially the handheld Doppler imaging and fetal screening through ultrasound devices carried out every trimester during pregnancy to estimate the gestational age.

The non-invasive method is expected to dominate the market, as most of the devices used are non-invasive in nature and provide accurate, real-time images, and continues results as compared to the invasive method. The non-portable segment accounted for the largest share in the global fetal monitoring market in 2019.

Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/1890

Based on application, antepartum fetal monitoring held the largest share in 2015 compared to intrapartum fetal monitoring. Hospitals is expected to maintain its dominant position throughout the analysis period, as they are leading users of fetal monitoring devices to deliver best maternal and fetal care.

Asia-Pacific has witnessed highest growth rate for fetal monitoring devices, and is expected to continue this trend due to increase in healthcare infrastructural development and high fertility rate, specifically in China and India.

Prominent players operating in the fetal monitoring market have adopted product launch as their key strategy, and focus on launching innovative products to cater to the consumer requirements and strengthen their market share.

The major companies profiled Are:

·        GE Healthcare

·        Analogic Corporation

·        Fujifilm Sonosite, Inc.

·        Koninklijke Philips N.V.

·        Siemens Healthcare

·        Medtronic Plc

·        Arjohuntleigh (subsidiary of Getinge AB)

·        Neoventa Medical AB

·        Natus Medical Incorporated

·        Spacelabs Healthcare (subsidiary of OSI Systems).

Key Findings Of The Study 

  • The study provides an in-depth analysis, current trends, and future estimations of the global fetal monitoring market to elucidate the imminent investment pockets.
  • Comprehensive analysis of factors that drive and restrict the fetal monitoring market growth is provided.
  • The electronic fetal monitoring (EFM) segment in product type is anticipated to grow at a CAGR of 6.2% from 2020 to 2027.
  • Extensive analyses of key segments of the fetal monitoring industry help to understand the types of products and technologies used across various geographies.

Access Full Report @ https://www.alliedmarketresearch.com/fetal-monitoring-market

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Wednesday, May 19, 2021

Scaffold Technology Market – By Current Scenario with Growth Rate 2027



Scaffolds mimic the extracellular matrix of the native tissue, recapitulating the in vivo milieu and allowing cells to influence their own microenvironments. They usually serve purposes such as allow cell attachment and migration, deliver & retain cells and biochemical factors, and exert certain mechanical & biological influences to modify the behavior of the cell phase. In addition, scaffold can act as a delivery vehicle for exogenous cells and matrix for cell adhesion to facilitate certain unit cell processes (for example, mitosis, synthesis, migration) of cells in vivo or for cells seeded in vitro. It also serves as a barrier to prevent the infiltration of surrounding tissue that may impede the process of regeneration. Scaffold technology technique is gaining popularity in the healthcare research sector, owing to increased demand for body reconstruction procedures and tissue engineering.

The global scaffold technology market was valued at $398.91 million in 2019, and is projected to reach $1,257.17 million by 2027, registering a CAGR of 16.9% from 2020 to 2027. 

Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/11468

The impact of COVID-19 pandemic is expected to remain moderate for pharmaceutical and biotechnological companies in the scaffold technology industry. The companies are facing a setback, owing to the lockdown, which led to a drop in the manufacturing and use of 3D cell culture among researchers. However, this lethal impact is being compensated by rapid development in stem cell therapy research and increase R&D for developing regenerative medicines for treating COVID-19 patients.

Rise in demand for 3D cell cultures in comparison to 2D cell culture, increase in usage of biomaterials, and growth of technological advancements of scaffold technology drive the growth of the scaffold technology market. However, high costs associated with implementation and emergence of scaffold-free technology for cell culturing are expected to hamper the growth of the market. On the contrary, increase in expenditure on R&D by governments in developing countries has growth potential in these countries.

Based on product type, the scaffold technology market is divided into natural scaffold and synthetic scaffold. On the basis of type, the market is fragmented into macro-porous scaffolds, micro-porous scaffolds, nano-porous scaffolds, and solid scaffolds. By end user, the market is segregated into biotechnology & pharmaceutical companies, contract research laboratories, and academic institutes. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Based on application, the market is divided into cancer research, stem cell research, drug discovery, regenerative medicine, and others. The cancer research segment dominated the global scaffold technology market in 2019, and is anticipated to maintain its dominance during forecast period. This is attributed to rise in prevalence of cancer, which has led to development of newer therapies for the prevention and treatment of cancer.

For Purchase Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/11468

North America accounted for the largest scaffold technology market share in 2019, and is anticipated to maintain its dominance from 2019 to 2027 due to high expenditure on R&D, presence of major players & their product availability, and well-established healthcare infrastructure in the region. However, Asia-Pacific is expected to register the highest CAGR during the forecast period as governments of Asian countries are investing in the development of healthcare infrastructure.

The Major Key Players Are:

3D Biotek LLC, Advanced Biomatrix, Inc., Agilent Technologies, Inc. (Biotek), BioVison, Incorporated, Corning Incorporated, Merck KGaA (Sigmaaldrich), PromoCell GmbH, Reprocell, Incorporation, Synthecon, Incorporated, and Thermo Fisher Scientific Inc.

Key Findings Of The Study

  • By type, the micro-porous scaffolds segment occupied the largest market share in the global scaffold technology market in 2019.
  • By application, the regenerative medicine segment is anticipated to grow with the highest CAGR during the forecast period.
  • By end user, the academic institutes segment held the largest market share in 2019, and is anticipated to maintain its dominance during the forecast period.
  • The U.S. contributed the highest revenue in 2019 in the market.
  • By region, Asia-Pacific is anticipated to experience 18.7% CAGR during the forecast period.

Access Full Report @ https://www.alliedmarketresearch.com/scaffold-technology-market-A11103

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

Monday, May 17, 2021

Chronic Hemodialysis Catheter Market – By Current Scenario with Growth Rate 2027



Hemodialysis is a process of blood purification in patients suffering from kidney disease by means of external hemodialyzer or artificial kidney. A hemodialyzer is connected to patient with the help of catheter and external tubing to facilitate efficient removal of wastes such as urea and extra fluid from blood. Hemodialysis catheter is implanted into patient’s vein to provide vascular access during dialysis process for efficient transfer of blood from patient to dialysis machine. A catheter consists of tubes, hub, extension, clamps, and cuffs.

The global chronic hemodialysis catheter market size was valued at $354 million in 2019, and is projected to reach $446 million by 2027, growing at a CAGR of 3.7% from 2020 to 2027.

Download Free Report Sample @ https://www.alliedmarketresearch.com/request-sample/6996

Rise in prevalence of kidney diseases is expected to result in surge in number of end-stage renal diseases (ESRD) patients around the globe, which is projected to boost the demand for hemodialysis catheters during the study period. In addition, technological advancements in hemodialysis catheters and lack of kidney donors are projected to fuel the chronic hemodialysis catheter market growth. Moreover, rise in utilization of hemodialysis catheters, increase in use of antimicrobial-coated hemodialysis catheters, surge in number of dialysis centers, and rise in patient awareness toward hemodialysis treatment are anticipated to drive growth of the market. However, complications associated with hemodialysis catheters and lack of access of hemodialysis catheters in underdeveloped countries is expected to hinder growth of the market.

COVID-19 is a large family of viruses that causes illness ranging from common cold to more severe diseases. A large number of coronavirus patients are suffering acute kidney damage, contributing to a rising need for onsite hemodialysis treatment in healthcare facilities. Thus, complications caused in the urinary system, by the COVID-19 infection is expected to maintain the demand for hemodialysis catheter products. This in turn, has limited the impact of COVID-19 on the chronic hemodialysis catheter market.  

By type of tip, the step-tip catheters segment dominates the global chronic hemodialysis catheter market, and is anticipated to continue this trend during the forecast period. The key factors such as increase in number of hemodialysis patients, rise in demand for step-tip hemodialysis catheters, increase in number of patients suffering from chronic kidney disorders (CKD), technological development in step-tip catheters and dialysis equipment, increase in awareness programs for hemodialysis treatment & management around the globe drive the market growth of this segment.

Inquire Before Buying @ https://www.alliedmarketresearch.com/purchase-enquiry/6996

On the basis of material, polyurethane segment accounts for the majority of chronic hemodialysis catheter market share, owing to advantages offered by polyurethane catheters such as good tensile strength & softness, bigger inner diameter for maximum blood flow, and requirement of less wall thickness for strength as compared to silicone. In addition, they are biocompatible and are good choice for long term catheterization. Moreover, surge in demand for double lumen polyurethane long-term hemodialysis catheters drive growth of the segment.

North America accounted for second largest share of the global chronic hemodialysis catheter market in 2019. This was attributed to increase in demand for hemodialysis catheter products, availability of well-developed infrastructure, presence of majority of key players, rise in number of patients suffering from chronic kidney disorders (CKD), and availability of trained medical professionals. 

However, Asia-Pacific is expected to experience the highest revenue and growth rate during the forecast period, majorly owing to improvement in healthcare infrastructure, rise in number of hospitals equipped with advanced medical facilities, development of the R&D sector, rise in healthcare reforms, and technological advancements in the field of healthcare.

Access Full Report @ https://www.alliedmarketresearch.com/chronic-hemodialysis-catheter-market-A06631

Key Findings Of The Study 

  • By type of tip, the step-tip catheters segment held largest chronic hemodialysis catheter market share in 2019, and is expected to remain dominant throughout the forecast period.
  • On the basis of material, the polyurethane segment held largest market share in 2019, and is expected to remain dominant throughout the forecast period. 
  • According to end user, the home dialysis segment exhibits fastest growth, and is expected to grow at a CAGR of 4.6% from 2020 to 2027.
  • Based on region, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 4.3% during the forecast period.

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

Neurostimulation Devices Market Size Prognosticated to Perceive a Thriving Growth by 2027



Rise in prevalence of lifestyle diseases such as depression and chronic pain, increase in number of neurological disorders, and investment for neurological R&D are some of the factors that drive the growth of the global neurostimulation devices market. Moreover, rise in demand for minimal invasive surgery, adoption of technologically advanced products, and surge in aging population further propel the growth of the market as they are more susceptible to neurological disorders, such as Epilepsy, Parkinson’s disease, Alzheimer’s disease, and chronic pain. The major barriers for the growth of the neurostimulation devices market are side effects such as allergic reaction and tingling or prickling of the skin due to implantation of neurostimulation device into the body and increase in device cost. However, the availability of other treatment options such as drug therapies and surgeries restrict the growth of the market.

The global neurostimulation devices market size is expected to reach $11.2 billion by 2026, registering a CAGR of 12.5% from 2019 to 2026, in terms of value. Neurostimulation functions by altering the pain signals that travel to the brain. Neurostimulation are programmable and implantable devices that deliver electrical stimulation to parts of brain, peripheral nervous system, and spinal cord. These devices are used to treat various medical conditions such as epilepsy, movement disorders, Parkinson's disease, and chronic pain.

Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/5558

The neurostimulation devices market is classified on the basis of device type, application, and region.

Based on device type, the market is divided into spinal cord stimulators, deep brain stimulators, sacral nerve stimulators, vagus nerve stimulators, and others. The spinal cord stimulators segment is the most lucrative segment in the global neurostimulation market. This is attributed to increase in usage of spinal cord stimulators for treating neuropathic pain and spinal injuries. In addition, upsurge in minimally invasive procedures and increase in healthcare spending further drive the neurostimulation devices market growth for spinal cord stimulators across the globe. The spinal cord stimulator segment is expected to grow at a significant CAGR, owing to usage of DBS in various diseases such as Parkinson's disease, obsessive-compulsive disorders, idiopathic dystonia, & essential tremor and growth in number of product approvals. According to global neurostimulation devices market analysis

The application segment is classified into pain management, hearing loss, urinary incontinence, Parkinson's disease, epilepsy, and others. The pain management segment is the highest contributor to the neurostimulation devices market in 2018, due to increase in usage of neurostimulation devices for treating chronic and acute pain. The hearing loss segment is anticipated to grow at a considerable CAGR, owing to rise in incidences of hearing loss across the globe. Approximately 48 million people are affected in America and nearly 360 million people globally, according to the data published by Hearing Health Foundation in 2020.

Region wise, it is studied across North America, Europe, Asia-Pacific, and LAMEA. The North America market accounted for the major share in the global neurostimulation devices market in 2018. Development of innovative neurostimulators, approvals by health authorities for novel techniques in neurostimulators, and mergers & acquisitions to acquire novel technologies & products are significant market trends in North America. Rise in prevalence of neurological disorders, increase in geriatric population, favorable reimbursement rates, and introduction of innovative technology are expected to drive of the market in this region. In addition, research and development activities to develop new technologies to manage pain and neurological disorders such as Parkinson’s disease, dystonia, and epilepsy are expected to increase the treatment options for patients and surgeons in the neurostimulation market. The market is expected to grow at a steady rate in future. The Asia-Pacific region offers lucrative opportunities to the players in the neurostimulator market, as it is anticipated to be the fastest growing market. Government and private initiatives to increase awareness regarding mental health and increase in incidence of neurological disorders drive the market growth. Factors such as improving healthcare infrastructure, rising number of healthcare reforms, and increasing healthcare expenditures in the emerging markets such as India and China to overcome the unmet medical needs in these regions boost the demand for neurostimulators.

Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/5558

The Major Key Players Are:

  • Abbott Laboratories
  • Alevaneurotherapeutics SA
  • Boston scientific corporation
  • Electro Core Inc.
  • Endo Stim Inc.
  • Medtronic plc
  • Neuro Pace Inc.
  • Nevro Corporation
  • Neuronetics Inc.
  • Neuro Sigma, Inc.
  • Synapse Biomedical Inc.

Key Market Benefits

  • North America occupied 40.0% share of the global neurostimulation devices market in 2018.
  • Asia-Pacific is anticipated to grow with the highest CAGR throughout the forecast period.
  • The spinal cord stimulators segment accounted for 49.9% share of the market in 2018. 
  • The pain management segment is anticipated to grow at the 14.5% during the analysis period.

Access Full Report @ https://www.alliedmarketresearch.com/neurostimulation-devices-market

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

Wednesday, May 12, 2021

Aerosol Delivery Devices Market To Receive Overwhelming Hike In Revenues By 2027


Aerosol delivery devices are generally used as facilitators to provide drugs to patients. Inhaled medication through lungs is mostly provided to prevent or relieve asthma, COPD and other respiratory & non-respiratory ailments. Advantages of aerosol delivery devices are direct deposition of inhaled medication to airway receptor sites, rapid onset of action of broncho-active drugs, and relative ease & convenience of self-administration by patients. Common classes of drugs suitable for aerosol delivery include anticholinergic antagonists, beta agonists, and anti-inflammatory agents.

The global aerosol delivery devices market was valued at $31,464 million in 2019, and is projected to reach $46,729 million by 2027, registering a CAGR of 4.9% from 2020 to 2027.

Download Free Report Sample @ https://www.alliedmarketresearch.com/request-sample/7153

The aerosol delivery devices market is expected to experience significant growth during the forecast period, owing to rise in prevalence of respiratory disorders such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis; rise in need for rescue medication during sudden asthmatic attack; and rise in demand for short-term, effective aerosol drug delivery devices. Moreover, increase in focus of manufacturers toward development of advanced, portable inhalation devices, surge in public awareness toward inhalation therapy, introduction of novel and advanced aerosol delivery devices in customized shapes and sizes, rise in geriatric population, and easy reimbursement policies associated with inhalation therapy are anticipated to drive growth of the aerosol delivery devices market. However, complications and side-effects associated with drug inhalation and high cost associated with nebulizers are expected to hinder growth of the aerosol delivery devices market. On the basis of product, the market is categorized into dry powder inhalers, metered dose inhalers, and nebulizers.

Coronavirus (COVID-19) was discovered in late December in Hubei province of Wuhan city in China. There are no drugs that are currently licensed for COVID-19 treatment or prevention. Increase in number of R&D activities and rise in use of aerosol delivery devices in clinical studies to develop medicines for treatment of COVID-19 is anticpated show positive impact on the market. For instance, Synairgen a UK-based respiratory drug discovery & Development Company launched home-based clinical trial of its inhaled IFN-β1a solution (SNG001) in patients with COVID-19.The dry powder inhalers (DPI) segment will show significant aerosol delivery devices market growth during the forecast period, owing to rise in demand for DPI, surge in patient awareness toward effective & advanced respiratory devices, advancements in DPI drug delivery, and launch of cost effective products.

For Purchase Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/7153

On the basis of application, the market is segregated into asthma, chronic obstructive pulmonary disease, cystic fibrosis, and non-respiratory diseases. Presently, the asthma segment accounts for majority of the aerosol delivery devices market share, owing to rise in prevalence of asthma in both developed as well as developing countries, surge in demand for metered dose inhalers (MDIs) to treat asthma, rise in smoking population, increase in air pollution, and surge in geriatric population facing chronic respiratory problems.

North America accounted for 41.16% of the global aerosol delivery devices market share in 2019, and is expected to remain dominant throughout the forecast period. This was attributed to increase in number of asthma and COPD patients; higher healthcare awareness; early detection of respiratory diseases; availability of advanced healthcare facilities with trained medical professionals; rise in number of R&D activities, coupled with large presence of key players; and surge in investment made by governments in the healthcare system. However, Asia-Pacific is expected to experience highest growth during the forecast period, owing to improvement in healthcare infrastructure, rise in number of hospitals equipped with advanced medical facilities, rise in healthcare reforms, and technological advancements in the field of healthcare.

Access Full Report @ https://www.alliedmarketresearch.com/aerosol-delivery-devices-market-A06788

Key Findings Of The Study

  • By product, the metered dose inhalers segment held largest market share in 2019, and is expected to remain dominant throughout the forecast period.
  • On the basis of application, the asthma segment held largest market share in 2019, and is expected to remain dominant throughout the forecast period. 
  • According to distribution channel, the e-commerce segment exhibits fastest growth, and is expected to grow at a CAGR of 9.3% from 2020 to 2027.
  • Based on region, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 6.4% during the forecast period. 

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

Hemodialysis and Peritoneal Dialysis Market: Growth, Demand and Key Players to 2027



Hemodialysis (HD) is a medical procedure used to remove wastes from patient’s blood with chronic or acute kidney failure. The waste removal helps to maintain electrolyte balance in patient’s body and prevents accumulation of salts and wastes in blood. The procedure works similar to an artificial kidney by filtering the blood through a device called the hemodialyzer. The duration and frequency of HD are vital factors that impact the treatment quality. A lengthier treatment time may be advantageous, predominantly among patients with substantial volume overload. While standard treatment practices involve dialysis 3 times per week, the possible benefits of repeated treatments are presently being studied. During HD, blood is collected through one of 3 types of vascular access, namely, fistula, graft, or catheter. HD can be performed at a hospital, a dialysis center, or at patient’s home.

The global hemodialysis and peritoneal dialysis market was valued at $15.68 billion in 2019, and is projected to reach $22.16 billion by 2027, registering a CAGR of 6.0%.

Download Free Report Sample @ https://www.alliedmarketresearch.com/request-sample/3474

On the other hand, peritoneal dialysis (PD) uses inner lining of abdomen to filter blood when kidneys are not functioning effectively. This procedure is mostly performed at patient’s home and primarily works to remove excess fluid and toxins from patient’s blood. In PD, a catheter is placed in patient’s abdomen and dialysis solution (dialysate) is added to collect and remove waste from the body. Dialysate absorbs toxic substances and fluid from blood, using peritoneum as a filter. Peritoneal dialysis is administered either continuously or intermittently. For patients with low kidney function, continuous PD is recommended by healthcare professionals. 

The major factors that impact growth of the hemodialysis and peritoneal dialysis market include increase in number of patients with CKDs and ESRDs, rise in incidences of diabetes and hypertension, and surge in funding for development of new products. In addition, problems accompanying kidney transplantation, rise in number of aged population, and increase in disposable income are estimated to possibly boost the market growth. Besides, on an account of lesser number of matching organ donor availability, dialysis is preferred over kidney transplant in most patient population, which probably fuels the market growth further. However, complications involved in dialysis treatment and uneven reimbursements for dialysis in developing countries are expected to hinder the hemodialysis and peritoneal dialysis market growth.

Inquire Before Buying @ https://www.alliedmarketresearch.com/purchase-enquiry/3474

The global hemodialysis and peritoneal dialysis market is segmented on the basis of type, dialysis site, modality, product, and region. By type, it is bifurcated into hemodialysis and peritoneal dialysis. The hemodialysis segment is further divided into short-term catheter, chronic catheter, graft, and fistula. By dialysis site, the market is classified into hospitals, clinics & dialysis centers, and home dialysis. By modality, it is categorized into conventional and daily (day time, night time). By product, it is segmented into devices and consumables. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. 

By type, the hemodialysis segment is the major contributor toward market growth, owing to the maturity of the market and it being the preferred form of approach among healthcare professionals and patients suffering from ESRD. Majority of patients opt for hemodialysis, however, owing to efficient removal of toxic substances and rise in demand for homecare among dialysis patients, peritoneal dialysis is expected to be the fastest growing segment during the forecast period. By dialysis site, most patients prefer to receive dialysis treatments through services provided by dialysis centers making them the largest contributor to the global market. Nonetheless, rise in awareness and surge in demand for home healthcare among dialysis patients is expected to boost the home dialysis segment during the forecast period.

By modality, conventional hemodialysis is more frequently used treatment, however, owing to efficient removal of toxic substances and demand for homecare among dialysis patients, daily dialysis is expected to be the fastest growing segment during the forecast period. By product, the consumable segment is expected to be the fastest growing segment as these products are used frequently and constantly replaced with new ones.

In 2019, Asia-Pacific accounted for maximum contribution to the total revenue generated, owing to high prevalence rate of diabetes and hypertension, presence of high disposable income, and high adoption rate of technologically advanced products. Moreover, presence of large number of dialysis centers in this region and rise in number of patients with chronic renal diseases are expected to boost the market growth.

Access Full Report @ https://www.alliedmarketresearch.com/hemodialysis-and-peritoneal-dialysis-market

The Major Key Players Are:

Fresenius Medical Care AG & Co. KGaA, Baxter International Inc., Nipro Corporation, B Braun Melsungen Ag, Nikkiso Co., Ltd., Becton, Dickinson And Company (C. R. Bard, Inc.), Cook Group, Angiodynamics Inc., Medtronic PLC, and Asahi Kasei Corp.

Key Findings Of The Study 

  • By modality, the conventional hemodialysis segment occupied a major share in 2019 and is expected to maintain the trend throughout the forecast period. 
  • The consumables segment is expected to grow with the highest CAGR during the forecast period. 
  • Hemodialysis segment held a major share in the global market in 2019 and is expected to retain it throughout the forecast period. 
  • Asia-Pacific is expected to be the fastest growing region, during the forecast period.

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com

Web: https://www.alliedmarketresearch.com 

Monday, May 10, 2021

Healthcare Payer Solution Market: Recent Industry Trends and Projected Industry Size by 2020-2027



The healthcare payer solution providers support the public and private payers as well as healthcare insurers to manage the claims, member engagement, audits, medical documents, and customer relations. These businesses have dedicated units, which improve the overall health system performance through optimizing care quality; reducing costs as well as improving consumer experience & care provider performance; and leveraging distinctive capabilities in data & analytics, pharmacy care services, population health, healthcare delivery, & healthcare operations. Through all these services, healthcare payer solution providers help their clients to improve their operational efficiency and reduce their operational cost.

The global healthcare payer solution market was valued at $19,409.52 million in 2019, and is projected to reach $41,906.64 million by 2027, registering a CAGR of 10.6% from 2020 to 2027.

Click Here To Access Free Sample Report @ https://www.alliedmarketresearch.com/request-sample/2809

Rise in cost of healthcare system and urge to decrease wasteful spending are the key driving forces of the global healthcare payer solution market. In addition, payers suffer from significant losses due to increase in healthcare frauds, which further boosts the need for healthcare payer solutions, thereby contributing toward the growth of the global market. Moreover, significant increase has been witnessed in health insurance enrolment, which positively impacts the growth of the market. 

Furthermore, increase in use of healthcare IT solutions and implementation of various healthcare reforms fuel the growth of the healthcare payer solution market. However, surge in incidences of data breaches and loss of confidentiality and cultural & language barriers are anticipated to hamper the growth of the market. Conversely, potential growth opportunities offered by emerging economies and increase in adoption of AI & analytics are expected to offer remunerative opportunities for the market growth during the forecast period.

The recent outbreak of the COVID-19 pandemic has disrupted the healthcare system of all the worst affected countries, owing to the alarming rise in number of patients diagnosed with COVID-19. It is expected that due to this overburden of COVID-19 on the healthcare system, it will lead to huge losses in administrative operation. The outsourcing partners who are having track record of improved efficiencies in the claim operations, provider network management, medical document management, fraud management, and all other applications are expected to help the payers in the market. In addition,surge in demand for health coverage in emerging markets due to the COVID-19 pandemic and increase in health insurance awareness among previously uninsured patients is likely to boost the growth of the healthcare payer solution market.

For Purchase Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/2809

The global healthcare payer solution market is segmented into service, application, end user, and region. On the basis of service, the market is segregated into business process outsourcing (BPO) services, information technology outsourcing (ITO) services, and knowledge process outsourcing (KPO) services. 

The applications covered in the study include pharmacy audit & analysis systems, claims management services, fraud management services, computer-assisted coding (CAC) systems, member eligibility management services, provider network management services, payment management services, customer relationship management services, medical document management services, and general ledger & payroll management.

On the basis of end user, the market is bifurcated into private and public end user. Region wise, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, the UK, Italy, Spain, France, and rest of Europe), Asia-Pacific (Japan, China, India, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). 

By service, the business process outsourcing services segment acquired the major share of the healthcare payer solution market, and is expected to experience rapid growth during the forecast period due to high demand of BPO services. Moreover, surge in investment by key players in cloud computing to strengthen their portfolio is augments the growth of the healthcare business process outsourcing services market. 

By application, the claims management services segment dominated the market, owing to urge in bringing down the wasteful spending in healthcare and increase in demand to streamline the process. However, the computer-assisted coding (CAC) systems segment is expected to grow at the fastest rate during the forecast period, due to increase in implementation of ICD-10 code globally.

Region wise, North America acquired a major share of the market, owing to presence of key players that offer healthcare payer solutions in the region and high demand for healthcare payer solutions. However, Asia-Pacific is expected to grow at the fastest rate during the forecast period, due to increase in adoption of healthcare IT solutions and presence of large uninsured population base that offers significant opportunities for the growth of the market. 

In addition, emerging economies offer lucrative opportunities for healthcare payer solution providers to expand their business. Furthermore, the constantly evolving healthcare industry drives the growth of the market in the developing economies such as India and China.

Access Full Report @ https://www.alliedmarketresearch.com/healthcare-payer-solution-market

The Major Key Players Are:

UnitedHealth Group Incorporated, McKesson Corporation, HMS Holdings Corp, International Business Machines Corporation, Change Healthcare, Inc., Accenture plc, Cognizant Technology Solutions Corporation, Hinduja Global Solutions Limited, Inovalon Holdings, Inc., and Wipro Limited.

Key Findings Of The Study 

  • Depending on service, the business process outsourcing services segment accounted for a share of nearly 52.2% in the healthcare payer solution market in 2019.
  • Region wise, Asia-Pacific is anticipated to grow with the highest CAGR of 11.3% throughout the forecast period.
  • North America accounted 32.4% of the global healthcare payer solution market in 2019. 
  • On the basis of application, the claims management services segment accounted for a share of 24.4% in the healthcare payer solution market in 2019.

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com